November 14, 2019 — The U.S. Food and Drug Administration today approved Fetroja (cefiderocol), an antibacterial drug for treatment of patients 18 years of age or older with complicated urinary tract infections (cUTI), including kidney infections…Original Article
FDA Approves Fetroja (cefiderocol) for the Treatment of Complicated Urinary Tract Infections
